Monday, August 22, 2011
BioTime Receives NIH Approval for Four Human Embryonic Stem Cell Lines
BioTime Receives NIH Approval for Four GMP Human Embryonic Stem Cell Lines - MarketWatch: Four human embryonic stem cell lines (ESI-035, ESI-049, ESI-051 and ESI-053), developed by a BioTime subsidiary have been approved by the National Institutes of Health for inclusion in the NIH Human Embryonic Stem Cell Registry. This approval opens the door to the use of these cell lines in federally funded research.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment